New Research Shows Quadrivalent HPV Vaccine is Safe Among Women with HIV

Data published in Clinical Infectious Diseases show that that the quadrivalent HPV vaccine is safe and immunogenic in women aged 13 to 45 with HIV. As Erna Milunka Kojic, MD, associate professor of medicine at Brown University, told Infectious Disease News, “HIV-infected women carry a disproportionate burden of HPV-associated diseases,” so this new information will benefit an important at-risk group.

 

Read more about the newly released research on the use of the quadrivalent HPV vaccine in women with HIV:

http://www.healio.com/infectious-disease/vaccine-preventable-diseases/news/online/%7Ba98e11bc-1d7c-4467-9de7-8e59c85d753d%7D/quadrivalent-hpv-vaccine-effective-in-women-with-hiv